AKT1 and neoplasm: TQ significantly augments cisplatin-induced anti-tumor effects on gastric cancer both in vitro and in vivo by blocking the PI3K/AKT signaling pathway, according to research done with SGC-7901 human gastric cancer cells and BALB/c mice implanted with gastric cancer cells [239].